The Merchant Shipping and Fishing Vessels (Health and Safety at Work) (Carcinogens and Mutagens) Regulations 2007

Regulation 2

SCHEDULE 1 U.K. OTHER SUBSTANCES AND PROCESSES TO WHICH THE DEFINITION OF CARCINOGEN RELATES

Aflatoxins.

Arsenic.

Auramine manufacture.

Work involving exposure to dusts, fumes and sprays produced during the roasting and electro-refining of cupro-nickel mattes.

Work involving exposure to polycyclic aromatic hydrocarbons present in coal soot, coal tar or coal pitch

Hardwood dusts.

[F1 Work involving exposure to respirable crystalline silica dust generated by a work process.]

Textual Amendments

F1 Words in Sch. 1 inserted (2.3.2020) by The Carcinogens and Mutagens (Miscellaneous Amendments) Regulations 2020 (S.I. 2020/40), regs. 1, 5(2)

Isopropyl alcohol manufacture (strong acid process).

Leather dust in boot and shoe manufacture, arising during preparation and finishing.

Magenta manufacture.

Mustard gas (beta, beta'- dicholorodiethyl sulphide).

Rubber manufacturing and processing giving rise to rubber process dust and rubber fume.

Used engine oils.

The following polychlorodibenzodioxins—

• 2,3,7,8-TCCD

• 1,2,3,7,8-PeCDD

• 1,2,3,4,7,8-HxCDD

• 1,2,3,6,7,8-HxCDD

• 1,2,3,7,8,9-HxCDD

• 1,2,3,4,6,7,8-HpCDD

• OCDD.

The following polychlorodibenzofurans—

• 2,3,7,8-TCDF

• 2,3,4,7,8-PeCDF

• 1,2,3,7,8-PeCDF

• 1,2,3,4,7,8-HxCDF

• 1,2,3,7,8,9-HxCDF

• 1,2,3,6,7,8-HxCDF

• 2,3,4,6,7,8-HxCDF

• 1,2,3,4,6,7,8-HpCDF

• 1,2,3,4,7,8,9-HpCDF

• OCDF.

Where T=tetra, Pe=penta, Hx=hexa, Hp=hepta and O=octa.

Regulation 6(2)

[F2 SCHEDULE 2 U.K. TABLE OF LIMIT VALUES

Textual Amendments

F2 Sch. 2 substituted (2.3.2020) by The Carcinogens and Mutagens (Miscellaneous Amendments) Regulations 2020 (S.I. 2020/40), reg. 1, Sch.

Name of agent	EC No	CAS No	Limit values			Notation	Transitional measures
			mg/m3	ppm	f/ml
(1) EC No, i.e. Einecs, ELINCS or NLP, is the official number of the substance within the European Union, as defined in Section 1.1.1.2 in Annex VI, Part 1, to Regulation (EC) No 1272/2008.
(2) CAS No: Chemical Abstract Service Registry Number.
(3) Measured or calculated in relation to a reference period of eight hours.
(4) mg/m3 = milligrams per cubic metre of air at 20 °C and 101,3 kPa (760 mm mercury pressure).
(5) ppm = parts per million by volume in air (ml/m3).
(6) f/ml = fibres per millilitre.
(7) Inhalable fraction: if hardwood dusts are mixed with other wood dusts, the limit value shall apply to all wood dusts present in that mixture.
(8) Respirable fraction.
(9) Substantial contribution to the total body burden via dermal exposure possible.]
Hardwood dusts	—	—	2	—	—	—	Limit value 3 mg/m3 until 17 January 2023
Chromium (VI) compounds which are carcinogens within the meaning of point (i) of Article 2(a) (as chromium)	—	—	0,005	—	—	—	Limit values: 0,025 mg/m3 for welding or plasma cutting processes or similar work processes that generate fume until 17 January 2025, and 0,010 mg/m3 until 17 January 2025 in all other cases
Refractory ceramic fibres which are carcinogens within the meaning of point (i) of Article 2(a)	—	—	—	—	0,3	—
Respirable crystalline silica dust	—	—	0,1	—	—	—
Benzene	200-753-7	71-43-2	3,25	1	—	skin
Vinyl chloride monomer	200-831-0	75-01-4	2,6	1	—	—
Ethylene oxide	200-849-9	75-21-8	1,8	1	—	skin
1,2-Epoxypropane	200-879-2	75-56-9	2,4	1	—	—
Acrylamide	201-173-7	79-06-1	0,1	—	—	skin
2-Nitropropane	201-209-1	79-46-9	18	5	—	—
o-Toluidine	202-429-0	95-53-4	0,5	0,1	—	skin
1,3-Butadiene	203-450-8	106-99-0	2,2	1	—	—
Hydrazine	206-114-9	302-01-2	0,013	0,01	—	skin
Bromoethylene	209-800-6	593-60-2	4,4	1	—	—

Regulation 6(6)

SCHEDULE 3 U.K. MEASURES TO BE TAKEN BY THE EMPLOYER

1.  Limitation of the quantities of a carcinogen or mutagen at the place of work. U.K.

2.  Keeping as low as possible the number of workers exposed or likely to be exposed. U.K.

3.  Design of work processes and engineering control measures so as to avoid or minimise the release of carcinogens or mutagens into the place of work. U.K.

4.  Evacuation of carcinogens or mutagens at source, local extraction system or general ventilation, all such methods to be appropriate and compatible with the need to protect public health and the environment. U.K.

5.  Use of existing appropriate procedures for the measurement of carcinogens or mutagens, in particular for the early detection of abnormal exposures resulting from an unforeseeable event or an accident. U.K.

6.  Application of suitable working procedures and methods. U.K.

7.  Collective protection measures. U.K.

8.  Where exposure cannot be avoided by other means, individual protection measures taken on their own or together with collective protection measures. U.K.

9.  Hygiene measures, including in particular regular cleaning of floors, walls and other surfaces. U.K.

10.  Information for workers. U.K.

11.  Demarcation of risk areas and use of adequate warning and safety signs including no smoking signs in areas where workers are exposed or likely to be exposed to carcinogens or mutagens. U.K.

12.  Drawing up plans to deal with emergencies likely to result in abnormally high exposure. U.K.

13.  Means for safe storage, handling and transportation, in particular using sealed and clearly and visibly labelled containers. U.K.

14.  Means for safe collection, storage and disposal of waste by workers, including the use of sealed and clearly and visibly labelled containers. U.K.

Regulation 14(8)

SCHEDULE 4 U.K. PRACTICAL RECOMMENDATIONS FOR THE HEALTH SURVEILLANCE OF WORKERS

1.  The doctor or authority responsible for the health monitoring of workers exposed to carcinogens or mutagens must be familiar with the exposure conditions or circumstances of each worker. U.K.

2.  Health monitoring of workers must be carried out in accordance with the principles and practices of occupational medicine and must include at least the following measures— U.K.

(a) keeping records of a worker's medical and occupational history;

(b) a personal interview;

(c) where appropriate, biological monitoring, as well as detection of early and reversible effects.

3.  Further tests may be decided upon for each worker when he is the subject of health monitoring, in the light of the most recent knowledge available to occupational medicine. U.K.